|
| 產(chǎn)地 | 進口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號 | CS10101 |
| 應(yīng)用范圍 | ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號 | |
| 抗體名 | Anti-ox-LDL |
| 克隆性 | |
| 靶點 | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標識物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | Full length plasma protein (Human) |
中文名稱 氧化抗體費用
英文名稱 Anti-ox-LDL
別 名 ox-LDL: Cu2SO4 oxidized low density lipoprotein; oxidized low density lipoprotein; Low density lipoprotein; MDA oxidized LDL; MDA oxidized low density lipoprotein; OLR1_HUMAN; Oxidized low-density lipoprotein receptor 1; Ox-LDL receptor 1; C-type lectin domain family 8 member A; Lectin-like oxidized LDL receptor 1; LOX-1; Lectin-like oxLDL receptor 1; hLOX-1; Lectin-type oxidized LDL receptor 1; Oxidized low-density lipoprotein receptor 1, soluble form..
產(chǎn)品屬性：
氧化抗體費用 濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg 1mg/1mg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human
產(chǎn)品類型 一抗
研究領(lǐng)域 心 細胞生物 免疫學 脂蛋白
蛋白分子量 predicted molecular weight: 31kDa
性 狀 Lyophilized or Liquid
免 疫 原 Full length plasma protein (Human)
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
氧化抗體費用 產(chǎn)品應(yīng)用 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Low-density lipoprotein (LDL) is the carrier protein for cholesterol in the blood. LDL binds to its receptor on the capillary walls and thereby mediates the uptake and clearence of cholesterol from the circulation. In atherosclerotic lesions oxidatively modified LDL is found and oxidized LDL is specifically recognized and ingested by macrophages via scavenger receptor A and CD36. Oxidized LDL may be a marker of atherosclerosis but the precise changes in oxidized LDL are not well described. Low-density lipoprotein oxidised with Cu2SO4.
Function : Receptor that mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells. OxLDL is a marker of atherosclerosis that induces vascular endothelial cell activation and dysfunction, resulting in pro-inflammatory responses, pro-oxidative conditions and apoptosis. Its association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. In addition to binding oxLDL, it acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. Also involved in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation. Also acts as a receptor for advanced glycation end (AGE) products, activated platelets, monocytes, apoptotic cells and both Gram-negative and Gram-positive bacteria.
Subunit : Homodimer; disulfide-linked. May form a hexamer composed of 3 homodimers. Interacts with HSP70.
Subcellular Location : Cell membrane; Single-pass type II membrane protein. Secreted. Note=A secreted form also exists.
Tissue Specificity : Expressed at high level in endothelial cells and vascular-rich organs such as placenta, lung, liver and brain, aortic intima, bone marrow, spinal cord and substantia nigra. Also expressed at the surface of dendritic cells. Widely expressed at intermediate and low level.
Post-translational modifications : N-glycosylated.
DISEASE : Note=Independent association genetic studies have implicated OLR1 gene variants in myocardial infarction susceptibility.
Note=OLR1 may be involved in Alzheimer disease (AD). Involvement in AD is however unclear: according to some authors (PubMed:12354387, PubMed:12810610 and PubMed:15976314), variations in OLR1 modify the risk of AD, while according to other (PubMed:15000751 and PubMed:15060104) they do not.
Similarity : Contains 1 C-type lectin domain.
Database links : UniProtKB/Swiss-Prot: P78380.1
氧化是(low density lipoprotein,LDL)經(jīng)氧化修飾后形成的,經(jīng)研究認為:OXLDL的增高與性心(Arteriosclerosis cardiovascular disease,ASCVD)的發(fā)生有密切關(guān)系。
實驗流程：
全、新、優(yōu)、品、好四大特點：
氧化抗體費用 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標準品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
技術(shù)外包服務(wù):
★氧化抗體費用 分子生物學：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學：基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構(gòu)建、細胞RNAi技術(shù)等等。
正在熱銷的相關(guān)產(chǎn)品：
Mcl-1(myeloid cell leukemia 1) peptide 髓樣細胞-1抗原Multi-class antibodies規(guī)格： 0.5mg
Anti-phospho-AMPK beta 1(Ser182) 磷酸化腺苷單磷酸活化蛋白激酶β1抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh phospho-B-Raf (Ser444) 磷酸化B-Raf抗體 規(guī)格 0.1ml
Tris- HCl-TWEEN 20緩沖液 100ml 0.5mol/L pH7.6
VEGF-B 英文名稱： 內(nèi)皮生長因子B抗體 0.1ml
DUOX2 英文名稱： 雙氧化酶2/甲狀腺氧化酶2抗體 0.2ml
Anti-phospho-AMPK beta 1(Ser182) 磷酸化腺苷單磷酸活化蛋白激酶β1抗體Multi-class antibodies規(guī)格： 0.1ml
SNAP-25 (synaptosomal-associated protein 25) 突觸相關(guān)膜蛋白25抗原Multi-class antibodies規(guī)格： 0.5mg
Anti-BMP6 骨形態(tài)發(fā)生蛋白6抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh PFK2/PFKFB3 6磷酸果糖激酶2抗體 規(guī)格 0.2ml
Cyclin D1 濃縮液 0.1ml 進口分裝
TPST2 英文名稱： 酪蛋白轉(zhuǎn)移酶2抗體 0.2ml
CCL12 英文名稱： 單核細胞趨化蛋白5抗體 0.2ml
Anti-BMP6 骨形態(tài)發(fā)生蛋白6抗體Multi-class antibodies規(guī)格： 0.1ml
E3 ELISA Kit 大鼠雌三醇Multi-class antibodies規(guī)格： 48T
Anti-ATP2c1/Ca++ ATPase/FITC 熒光素標記鈣離子ATP酶通道蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh Factor VII light chain 凝血因子VII 規(guī)格 0.2ml
c ELISA Kit 大鼠心肌特異性肌鈣蛋白T 96T
MelanA 英文名稱： 相關(guān)抗原/黑色素-A抗體 0.1ml
phospho-AMPK alpha-1 (Thr198) 英文名稱： 磷酸化腺苷單磷酸活化蛋白激酶α1抗體 0.1ml
Anti-ATP2c1/Ca++ ATPase/FITC 熒光素標記鈣離子ATP酶通道蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml
SCGB1A1 Protein Mouse 重組小鼠 Uteroglobin / SCGB1A1 蛋白 (His 標簽)
MDA-MB-415 人腺癌細胞
MERTK Others Mouse 小鼠 MERTK / MER 人細胞裂解液 (陽性對照)
HFL1人胚 HFL1 in human embryo lung fibroblasts F12K培養(yǎng)基+10%FBS
小鼠骨髓細胞;FDC-P1
人胚腎二倍體細胞;CCC-HEK-1 人氣管上皮細胞完全培養(yǎng)基 100mL
CL-0286M1(小鼠細胞)5×106cells/瓶×2
HA Others H3N2 甲型 H3N2 (A/Victoria/210/2009) 血凝素HA1 (Hemagglutinin) 人細胞裂解液 (陽性對照)
人滋養(yǎng)層絨毛細胞cDNAHVT cDNA
豬腎細胞;LLC-PK1 人惡性非霍奇金患者的自然殺傷細胞，NK-92細胞 P615細胞，615小鼠狀肺腺株
Asp2人胚胎腎細胞轉(zhuǎn)化細胞;FC33
HA Others H5N1 甲型 H5N1 (A/duck/Hunan/795/2002) 血凝素HA1 (Hemagglutinin) 人細胞裂解液 (陽性對照)
氧化抗體費用 SCGB1A1 Protein Mouse 重組小鼠 Uteroglobin / SCGB1A1 蛋白 (His 標簽)
MDA-MB-415 人腺癌細胞
MERTK Others Mouse 小鼠 MERTK / MER 人細胞裂解液 (陽性對照)
HFL1人胚 HFL1 in human embryo lung fibroblasts F12K培養(yǎng)基+10%FBS
小鼠骨髓細胞;FDC-P1
人胚腎二倍體細胞;CCC-HEK-1 人氣管上皮細胞完全培養(yǎng)基 100mL
|
|
|
|
|
